Peptides, NAD+, and ADHD: separating signal from supplement hype

What did @unprescribed1 actually say?

The creator made two distinct claims worth separating. First, that NAD+ is a peptide. Second, and more attention-grabbing, that three months of NAD+ supplementation allowed them to cut their prescribed stimulant dose in half after a lifetime of ADHD medication use starting at age five. They also noted a reduced desire for caffeine and framed this as an underreported benefit of NAD+. The video is personal testimony, not protocol advice, and they acknowledge they haven't seen others talking about it, which is at least intellectually honest.

The tone is enthusiastic but genuinely curious. They're asking for community input, not selling a product. That counts for something. But the core claims, particularly that NAD+ drove their reduced stimulant need, are doing a lot of work without any mechanism explained or alternative explanations considered.

Does the science back this up?

Partially, but not in the way the video implies. NAD+ precursors like NMN and NR have real research behind them, mostly in mitochondrial function and cellular energy metabolism. The ADHD angle, though, is almost entirely unexplored in clinical trials.

A 2023 review by Braidy et al. in Antioxidants and Redox Signaling confirmed that NAD+ plays a meaningful role in neuronal energy production and may support dopaminergic signaling pathways. Dopamine metabolism is directly relevant to ADHD, so the theoretical bridge is not absurd. However, theoretical bridges are not clinical evidence. One small 2021 pilot study by Serras et al. in Nutrients looked at NAD+ precursors in fatigue and cognitive function and found modest improvements in mental clarity, but it did not study ADHD populations or stimulant interaction. There is currently no peer-reviewed trial examining NAD+ supplementation as an adjunct to ADHD medication. The caffeine sensitivity reduction the creator mentions has no published research support at all.

What did they get wrong (or right)?

The biggest factual error is calling NAD+ a peptide. It is not. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme, a small molecule involved in redox reactions across virtually every cell in the body. Peptides are short chains of amino acids. These are chemically distinct categories. Calling NAD+ a peptide is like calling vitamin C a hormone. It belongs in a different bucket entirely, and that matters when people are researching what to ask their doctor about.

What they got right: the anti-aging research on NAD+ is legitimate and growing. A 2022 study by Lautrup et al. in Cell Metabolism linked declining NAD+ levels in aging neurons to cognitive decline, which is credible science. They also got credit for framing their experience as anecdote and asking for input rather than issuing advice. They never named a dose, which many creators in this space do recklessly.

What should you actually know?

If you have ADHD and are considering NAD+ supplementation, the honest answer is that we do not know whether it helps, and we definitely do not have evidence it can replace or reduce stimulant medication for most people. Individual responses to any intervention vary enormously, and one person's three-month experience is not a protocol.

More practically: NAD+ precursor supplements are widely available over the counter as NMN or NR, but IV NAD+ infusions require clinical oversight and carry cost and access barriers. Reducing a prescribed stimulant without medical supervision is risky, especially for someone who has managed ADHD since childhood. Changes in stimulant dosing should happen in partnership with a prescribing clinician who knows your full picture.

• NAD+ has plausible but unproven connections to dopamine metabolism relevant to ADHD.
• No clinical trial has studied NAD+ as an ADHD treatment or stimulant adjunct.
• Reducing prescribed stimulants based on a supplement response alone carries real risk.
• The caffeine sensitivity change described may reflect general wellbeing changes, sleep quality, or other lifestyle factors, not NAD+ specifically.